Literature DB >> 26611492

Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.

Brian K P Goh1,2, Jin-Yao Teo1, Chung-Yip Chan1, Ser-Yee Lee1, Premaraj Jeyaraj1, Peng-Chung Cheow1, Pierce K H Chow1,2,3, London L P J Ooi1,2, Alexander Y F Chung1.   

Abstract

BACKGROUND: Presently, the impact of tumors size as a prognostic factor after curative liver resection (LR) for solitary hepatocellular carcinoma (HCC) remains controversial. This study was performed to determine the prognostic factors of patients undergoing LR for solitary HCC with special emphasis on the importance of tumor size.
METHODS: Between 2000 and 2013, 560 patients underwent curative LR for solitary primary HCC which met the study criteria.
RESULTS: One-hundred and seventy-eight patients underwent major hepatectomies and the overall in-hospital mortality was 2.0%. There were 282 patients (50.4%) with liver cirrhosis. The 5-year overall survival (OS) was 64% and recurrence free survival (RFS) was 50%, respectively. Multivariate analyses demonstrated that cirrhosis, microvascular invasion and size were independent predictors of RFS and cirrhosis, microvascular invasion and age were independent prognostic factors of OS. Subset analysis demonstrated that tumor size was a prognostic factor for solitary HCC with microvascular invasion (AJCC T2) but not solitary HCC without microvascular invasion (AJCC T1).
CONCLUSIONS: Size, microvascular invasion, and cirrhosis are independent prognostic factors of RFS for solitary HCC after LR. Tumor size is an important prognostic factor in T2 but not T1 solitary tumors. These findings suggest that the current AJCC TNM staging system may need to be revised.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  American Joint Committee for Cancer; TNM; hepatocellular carcinoma; prognosis; resection; solitary; staging; survival

Mesh:

Year:  2015        PMID: 26611492     DOI: 10.1002/jso.24099

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  30 in total

1.  Perioperative Outcomes of Laparoscopic Repeat Liver Resection for Recurrent HCC: Comparison with Open Repeat Liver Resection for Recurrent HCC and Laparoscopic Resection for Primary HCC.

Authors:  Brian K P Goh; Nicholas Syn; Jin-Yao Teo; Yu-Xin Guo; Ser-Yee Lee; Peng-Chung Cheow; Pierce K H Chow; London L P J Ooi; Alexander Y F Chung; Chung-Yip Chan
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

Review 2.  Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Authors:  Luca Bertero; Federica Massa; Jasna Metovic; Roberto Zanetti; Isabella Castellano; Umberto Ricardi; Mauro Papotti; Paola Cassoni
Journal:  Virchows Arch       Date:  2017-12-05       Impact factor: 4.064

3.  Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.

Authors:  Xiao-Hui Wang; Bing Liao; Wen-Jie Hu; Cai-Xue Tu; Cai-Ling Xiang; Sheng-Hua Hao; Xian-Hai Mao; Xiao-Ming Qiu; Xiao-Jun Yang; Xiao Yue; Ming Kuang; Bao-Gang Peng; Shao-Qiang Li
Journal:  Oncologist       Date:  2020-08-06       Impact factor: 5.837

4.  Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.

Authors:  Junyi Shen; Linye He; Chuan Li; Tianfu Wen; Weixia Chen; Changli Lu; Lvnan Yan; Bo Li; Jiayin Yang
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

5.  Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular Carcinoma.

Authors:  Ye Jin; Zhi-Yong Liang; Wei-Xun Zhou; Li Zhou
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

6.  Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.

Authors:  Jing-Yi Zhang; Da Xu; Zhen-Zhen Liu; Yuan Li; Li-Jun Wang; Bao-Cai Xing
Journal:  Chin Med J (Engl)       Date:  2017-02-20       Impact factor: 2.628

7.  Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.

Authors:  Junyi Shen; Linye He; Chuan Li; Tianfu Wen; Weixia Chen; Changli Lu; Lvnan Yan; Bo Li; Jiayin Yang
Journal:  Oncotarget       Date:  2016-12-06

8.  Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion.

Authors:  Wenhao Chen; Zijian Zhang; Xianrui Fang; Li Xiong; Yu Wen; Jiangjiao Zhou; Fanhua Kong; Heng Zou
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

9.  A simple prognostic score system predicts the prognosis of solitary large hepatocellular carcinoma following hepatectomy.

Authors:  Jun-Yi Shen; Chuan Li; Tian-Fu Wen; Lv-Nan Yan; Bo Li; Wen-Tao Wang; Jia-Yin Yang; Ming-Qing Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.

Authors:  Oleg V Grinchuk; Surya P Yenamandra; Ramakrishnan Iyer; Malay Singh; Hwee Kuan Lee; Kiat Hon Lim; Pierce Kah-Hoe Chow; Vladamir A Kuznetsov
Journal:  Mol Oncol       Date:  2017-12-12       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.